SGS Expands Viral Trials: ‘Less Volunteers, Less Cost to Client’

- Last updated on GMT

Related tags: Avicenna

SGS expands clinical trial unit
SGS expands clinical trial unit
SGS says the expansion of its Belgian unit will offer a new approach in its clinical trials involving smaller sample sizes.

The viral challenge Testing facility, in Antwerp, Belgium, is to benefit from a new 12-bed quarantine facility which will allow SGS Life Science Services to conduct highly specialised clinical trials for the development of new-generation vaccines.

SGS said in a press release that this model differs from traditional community-based studies and will save clients money as the number of volunteers required to obtain meaningful results will be much lower.

Dr. Steven Ramael, SGS Life Science Services Medical Director said that “although the model does not necessarily reflect all parameters relevant to community-acquired infection, it does provide for a carefully controlled, systematic, and efficient method in which a number of variables can be controlled or even eliminated.”

Details of the facility include a negative pressure system and a dedicated laboratory containing a flow cabinet, acid cabinet, and a dedicated workspace in which to handle viral cultures. The expansion is Biosafety-Level 2-Q compliant.

Related news

Related products

show more

Shifting the Biomanufacturing Paradigm

Shifting the Biomanufacturing Paradigm

Take the Right Path Upstream with MilliporeSigma | 12-May-2020 | Technical / White Paper

The first commercial monoclonal antibody (mAb) was approved in 1986 and today, the global market is large and growing. Reports estimate the size of the...

Microaerobic Fermentation of Lactobacillus acidophilus

Microaerobic Fermentation of Lactobacillus acidophilus

Eppendorf for Bioprocess – Solutions that grow with you | 01-Oct-2019 | Application Note

We successfully performed microaerobic fermenta¬tion of a probiotic strain, Lactobacillus acidophilus, at a very low oxygen level, representing the natural...

Removing Aggregates of an Acidic Monoclonal Antibody

Removing Aggregates of an Acidic Monoclonal Antibody

Bio-Rad Laboratories | 22-Oct-2018 | Technical / White Paper

CHT Ceramic Hydroxyapatite Media/Resins are known as the industry gold standard for
impurity removal during monoclonal antibody (mAb) purification....

Related suppliers

Follow us


View more